Harrow Health (HROW) Misses Q2 EPS by 35c

Harrow Health (NASDAQ: HROW) reported Q2 EPS of ($0.46), $0.35 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $70.7 million versus the consensus estimate of $70.96 million.

For earnings history and earnings-related data on Harrow Health (HROW) click here.

You May Also Be Interested In

• FDA accepts Teva's drug application for Tourette syndrome therapy in children
• Planned Arctic Economic and Security Corridor All-Weather Road Positively Affects Sixty North Gold's Mon Gold Mine, NWT
• Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue